Activin a promotes the TGF-β-induced conversion of CD4 +CD25- T cells into Foxp3+ induced regulatory T cells

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4633-4640

  Huber, Samuel ^a   Stahl, Felix R ^a   Schrader, Jörg ^a   Lüth, Stefan ^a   Presser, Katrin ^a   Carambia, Antonella ^a   Flavell, Richard A ^b   Werner, Sabine ^c   Blessing, Manfred ^d   Herkel, Johannes ^a   Schramm, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; ACTIVIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; SMAD2 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ACTIVINS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 65249138364     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803143     Document Type: Article

References (48)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
2. + regulatory T cells. Nat. Immunol. 4: 330-336.
3. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770.
4. + regulatory T cells. Front. Biosci. 11: 1014-1023.
5. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
6. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
7. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol. 178: 2883-2892.
8. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201: 127-137.
9. Knoechel, B., J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202: 1375-1386. (Pubitemid 41668740)
10. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
11. + regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027.
12. Polansky, J. K., K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, S. Olek, A. Hamann, H. von Boehmer, and J. Huehn. 2008. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38: 1654-1663.
13. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
14. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
15. Lucas, P. J., S. J. Kim, S. J. Melby, and R. E. Gress. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J. Exp. Med. 191: 1187-1196.
16. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
17. Li, M. O., S. Sanjabi, and R. A. Flavell. 2006. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455-471.
18. Huber, S., C. Schramm, H. A. Lehr, A. Mann, S. Schmitt, C. Becker, M. Protschka, P. R. Galle, M. F. Neurath, and M. Blessing. 2004. Cutting edge: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol. 173: 6526-6531. (Pubitemid 39541034)
19. Marie, J. C., J. J. Letterio, M. Gavin, and A. Y. Rudensky. 2005. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201: 1061-1067.
20. Ling, N., S. Y. Ying, N. Ueno, S. Shimasaki, F. Esch, M. Hotta, and R. Guillemin. 1986. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321: 779-782. (Pubitemid 16077905)
21. Phillips, D. J., K. L. Jones, J. Y. Scheerlinck, M. P. Hedger, and D. M. de Kretser. 2001. Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol. Cell. Endocrinol. 180: 155-162.
22. ten Dijke, P., and C. S. Hill. 2004. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29: 265-273.
23. Attisano, L., J. L. Wrana, E. Montalvo, and J. Massague. 1996. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16: 1066-1073. (Pubitemid 26061678)
24. Chen, Y. G., Q. Wang, S. L. Lin, C. D. Chang, J. Chuang, and S. Y. Ying. 2006. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp. Biol. Med. (Maywood). 231: 534-544.
25. de Guise, C., A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J. J. Lebrun. 2006. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology 147: 4351-4362.
26. Krummen, L. A., T. K. Woodruff, G. DeGuzman, E. T. Cox, D. L. Baly, E. Mann, S. Garg, W. L. Wong, P. Cossum, and J. P. Mather. 1993. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. Endocrinology 132: 431-443.
27. Werner, S., and C. Alzheimer. 2006. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17: 157-171. (Pubitemid 43816894)
28. Ogawa, K., M. Funaba, L. S. Mathews, and T. Mizutani. 2000. Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J. Immunol. 165: 2997-3003.
29. Abe, M., Y. Shintani, Y. Eto, K. Harada, M. Kosaka, and T. Matsumoto. 2002. Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. J. Leukocyte Biol. 72: 347-352.
30. Cho, S. H., Z. Yao, S. W. Wang, R. F. Alban, R. G. Barbers, S. W. French, and C. K. Oh. 2003. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J. Immunol. 170: 4045-4052.
31. Ogawa, K., M. Funaba, Y. Chen, and M. Tsujimoto. 2006. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J. Immunol. 177: 6787-6794. (Pubitemid 44715043)
32. Jones, K. L., J. N. Brauman, N. P. Groome, D. M. de Kretser, and D. J. Phillips. 2000. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology 141: 1905-1908.
33. Jones, K. L., A. Mansell, S. Patella, B. J. Scott, M. P. Hedger, D. M. de Kretser, and D. J. Phillips. 2007. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc. Natl. Acad. Sci. USA 104: 16239-16244.
34. Yu, E. W., K. E. Dolter, L. E. Shao, and J. Yu. 1998. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 112: 126-132.
35. Nusing, R. M., and J. Barsig. 1999. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br. J. Pharmacol. 127: 919-926.
36. Hubner, G., M. Brauchle, M. Gregor, and S. Werner. 1997. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab. Invest. 77: 311-318. (Pubitemid 27465593)
37. Karagiannidis, C., G. Hense, C. Martin, M. Epstein, B. Ruckert, P. Y. Mantel, G. Menz, S. Uhlig, K. Blaser, and C. B. Schmidt-Weber. 2006. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β-mediated airway remodeling in asthma. J. Allergy Clin. Immunol. 117: 111-118. (Pubitemid 43017148)
38. Munz, B., H. Smola, F. Engelhardt, K. Bleuel, M. Brauchle, I. Lein, L. W. Evans, D. Huylebroeck, R. Balling, and S. Werner. 1999. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18: 5205-5215. (Pubitemid 29465571)
39. Wankell, M., B. Munz, G. Hubner, W. Hans, E. Wolf, A. Goppelt, and S. Werner. 2001. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J. 20: 5361-5372. (Pubitemid 32959456)
40. Schramm, C., M. Protschka, H. H. Kohler, J. Podlech, M. J. Reddehase, P. Schirmacher, P. R. Galle, A. W. Lohse, and M. Blessing. 2003. Impairment of TGF-β signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am. J. Physiol. 284: G525-G535. (Pubitemid 36227901)
41. Lüth, S., S. Huber, C. Schramm, T. Buch, S. Zander, C. Stadelmann, W. Brück, D. C. Wraith, J. Herkel, and A. W. Lohse. 2008. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J. Clin. Invest. 118: 3403-3410.
42. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
43. Huber, S., J. Schrader, G. Fritz, K. Presser, S. Schmitt, A. Waisman, S. Lüth, M. Blessing, J. Herkel, and C. Schramm. 2008. P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg. PLoS One 3: e3302.
44. Schramm, C., S. Huber, M. Protschka, P. Czochra, J. Burg, E. Schmitt, A. W. Lohse, P. R. Galle, and M. Blessing. 2004. TGFβ regulates the CD4+ CD25+ T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16: 1241-1249. (Pubitemid 39220423)
45. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Carcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
46. Valzasina, B., S. Piconese, C. Guiducci, and M. P. Colombo. 2006. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res. 66: 4488-4495.
47. Fantini, M. C., C. Becker, I. Tubbe, A. Nikolaev, H. A. Lehr, P. Galle, and M. F. Neurath. 2006. Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 55: 671-680.
48. Gorelik, L., and R. A. Flavell. 2002. Transforming growth factor-β in T-cell biology. Nat. Rev. Immunol. 2: 46-53. (Pubitemid 37328775)